Price loading...

The 2016-2021 Outlook for Pancreatic Cancer Drugs in the United States

Price data last checked 91 day(s) ago - refreshing...

View at Amazon

Price History & Forecast

No Price Data Available

Price history will appear here once data is collected from Amazon.

Price Distribution

No price data available for histogram

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
30 September 2015
Listed Since
02 June 2016

Similar Products You Might Like

The 2021-2026 World Outlook for Pancreatic Cancer Drugs
98% match

The 2021-2026 World Outlook for Pancreatic Cancer Drugs

£795.00 12 Jan 2026
The 2016-2021 Outlook for Liver Cancer Drugs in the United States
98% match

The 2016-2021 Outlook for Liver Cancer Drugs in the United States

£595.00 11 Jan 2026
The 2016-2021 Outlook for Non-Small Cell Lung Cancer Therapeutics in the United States
97% match

The 2016-2021 Outlook for Non-Small Cell Lung Cancer Therapeutics in the United States

£595.00 12 Jan 2026
The 2016-2021 Outlook for Hematology and Oncology Products in the United States
97% match

The 2016-2021 Outlook for Hematology and Oncology Products in the United States

£595.00 28 Feb 2026
The 2016-2021 Outlook for Lou Gehrig's Disease Drugs in the United States
97% match

The 2016-2021 Outlook for Lou Gehrig's Disease Drugs in the United States

£595.00 25 Jan 2026
The 2016-2021 Outlook for Protein Drugs in the United States
96% match

The 2016-2021 Outlook for Protein Drugs in the United States

£595.00 28 Jan 2026
The 2016-2021 Outlook for Pulmonary Drug Delivery Systems in the United States
96% match

The 2016-2021 Outlook for Pulmonary Drug Delivery Systems in the United States

£595.00 30 Jan 2026
The 2016-2021 World Outlook for Non-Small Cell Lung Cancer Therapeutics
96% match

The 2016-2021 World Outlook for Non-Small Cell Lung Cancer Therapeutics

£995.00 11 Jan 2026
The 2016-2021 Outlook for Systemic Antiviral Pharmaceuticals in the United States
96% match

The 2016-2021 Outlook for Systemic Antiviral Pharmaceuticals in the United States

£595.00 25 Jan 2026
The 2016-2021 Outlook for Non-Small Cell Lung Cancer Therapeutics in Greater China
96% match

The 2016-2021 Outlook for Non-Small Cell Lung Cancer Therapeutics in Greater China

£595.00 10 Mar 2026
The 2016-2021 Outlook for Generic Prescription Drugs in the United States
96% match

The 2016-2021 Outlook for Generic Prescription Drugs in the United States

£595.00 24 Jan 2026
The 2016-2021 Outlook for Topical Antiseptic Medications in the United States
96% match

The 2016-2021 Outlook for Topical Antiseptic Medications in the United States

£595.00 26 Jan 2026
The 2016-2021 Outlook for Erythropoietins in the United States
96% match

The 2016-2021 Outlook for Erythropoietins in the United States

£595.00 01 Feb 2026
The 2016-2021 Outlook for Liver Cancer Drugs in Japan
96% match

The 2016-2021 Outlook for Liver Cancer Drugs in Japan

£595.00 31 Jan 2026
The 2016-2021 Outlook for Medicated Candy in the United States
96% match

The 2016-2021 Outlook for Medicated Candy in the United States

£595.00 14 Jan 2026
The 2016-2021 Outlook for Topical Antibiotic Pharmaceuticals in the United States
96% match

The 2016-2021 Outlook for Topical Antibiotic Pharmaceuticals in the United States

£595.00 25 Jan 2026
The 2016-2021 Outlook for Motion Sickness Medications in the United States
96% match

The 2016-2021 Outlook for Motion Sickness Medications in the United States

£595.00 25 Jan 2026
The 2016-2021 Outlook for OTC Healthcare Products in the United States
96% match

The 2016-2021 Outlook for OTC Healthcare Products in the United States

£595.00 25 Jan 2026
The 2016-2021 Outlook for Hepatitis C Virus (HCV) Therapeutics in the United States
96% match

The 2016-2021 Outlook for Hepatitis C Virus (HCV) Therapeutics in the United States

£595.00 10 Dec 2025
The 2016-2021 Outlook for Peripheral Vasodilator Pharmaceuticals in the United States
96% match

The 2016-2021 Outlook for Peripheral Vasodilator Pharmaceuticals in the United States

£595.00 10 Mar 2026
The 2016-2021 Outlook for Multiple Sclerosis Therapeutics in the United States
96% match

The 2016-2021 Outlook for Multiple Sclerosis Therapeutics in the United States

£595.00 14 Jan 2026
The 2016-2021 Outlook for Small Molecule Kinase Inhibitors in the United States
96% match

The 2016-2021 Outlook for Small Molecule Kinase Inhibitors in the United States

£595.00 10 Dec 2025
The 2016-2021 Outlook for Nanomedicine in the United States
96% match

The 2016-2021 Outlook for Nanomedicine in the United States

£595.00 23 Jan 2026
The 2016-2021 Outlook for Stem Cell Products in the United States
96% match

The 2016-2021 Outlook for Stem Cell Products in the United States

£595.00 05 Feb 2026